For the year ending 2025-12-31, DERM made $61,858K in revenue. -$11,431K in net income. Net profit margin of -18.48%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 61,858 | 56,134 | ||
| Cost of goods sold - (excluding amortization of acquired intangible assets) | 20,924 | 20,879 | ||
| Amortization of acquired intangible assets | 4,258 | 3,424 | ||
| Research and development | 480 | 9,857 | ||
| Loss recovery | - | 4,553 | ||
| Selling, general and administrative | 44,368 | 40,204 | ||
| Total operating expenses | 70,030 | 69,811 | ||
| Loss from operations | -8,172 | -13,677 | ||
| Interest income | 589 | 757 | ||
| Interest expense | 3,698 | 2,700 | ||
| Gain on extinguishment of debt | - | 1,125 | ||
| Foreign exchange transaction losses | -90 | -116 | ||
| Total other expense | -3,199 | -934 | ||
| Loss before income taxes | -11,371 | -14,611 | ||
| State | 60 | - | ||
| Total current | 60 | - | ||
| Federal | -2,223 | - | ||
| State | -44 | - | ||
| Total deferred | -2,267 | - | ||
| Valuation allowance | 2,267 | - | ||
| Income tax expense | 60 | 61 | ||
| Net loss | -11,431 | -14,672 | ||
| Basic EPS | -0.47 | -0.72 | ||
| Diluted EPS | -0.47 | -0.72 | ||
| Basic Average Shares | 24,497,973 | 20,431,400 | ||
| Diluted Average Shares | 24,497,973 | 20,431,400 | ||
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)